SCHEDULE OF WARRANT ACTIVITY (Details) - Warrant [Member] - USD ($) |
6 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2025 |
Dec. 31, 2024 |
|||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Number of Warrants Outstanding and Vested, Balance | 16,668 | |||
Weighted Average Exercise Price, Outstanding and vested, Balance | $ 10.4999 | |||
Weighted Average Contractual Life (Years) | 9 months 14 days | |||
Aggregated Intrinsic Value, Balance | ||||
Number of Warrants Outstanding and Vested, Warrants Issued | [1] | 75,000 | ||
Weighted Average Exercise Price, Warrants Issued | [1] | $ 8.1250 | ||
Number of Warrants Outstanding and Vested, Balance | 91,668 | 16,668 | ||
Weighted Average Exercise Price, Outstanding and vested, Balance | $ 8.5568 | $ 10.4999 | ||
Weighted Average Contractual Life (Years) | 1 year 10 months 2 days | |||
Aggregated Intrinsic Value, Balance | ||||
|
X | ||||||||||
- Definition Weighted average exercise price, outstanding. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non options outstanding weighted average exercise price exercised. No definition available.
|
X | ||||||||||
- Definition Share-based compensation arrangement by share-based payment award non-options outstanding intrinsic value. No definition available.
|
X | ||||||||||
- Definition Share-based compensation arrangement by share-based payment award non-options weighted average remaining contractual term. No definition available.
|
X | ||||||||||
- Definition Share-based compensation arrangement by share-based payment award non-options weighted average remaining contractual term. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|